Biology Reference
In-Depth Information
8. Ebert MS, Sharp PA. Roles for MicroRNAs in confer-
ring robustness to biological processes. Cell 2012;
149
:
515
e
24.
9. Calin GA, Dumitru CD, Shimizu M, et al. Frequent
deletions and down-regulation of micro-RNA genes
miR15 and miR16 at 13q14 in chronic lymphocytic
leukemia. Proc Natl Acad Sci USA 2002;
99
:15524
e
9.
10. Calin GA, Sevignani C, Dumitru CD, et al. Human
microRNA genes are frequently located at fragile sites
and genomic regions involved in cancers. Proc Natl
Acad Sci USA 2004;
101
:2999
e
3004.
11. Esquela-Kerscher A, Slack FJ. Oncomirs
d
microRNAs
with a role in cancer. Nat Rev Cancer 2006;
6
:259
e
69.
12. Hammond SM. MicroRNAs as tumor suppressors. Nat
Genet 2007;
39
:582
e
3.
13. Ota A, Tagawa H, Karnan S, et al. Identi
24. Bonci D, Coppola V, Musumeci M, et al. The miR-15a-
miR-16-1 cluster controls prostate cancer by
targeting multiple oncogenic activities. Nat Med 2008;
14
:1271
e
7.
25. Bottoni A, Piccin D, Tagliati F, et al. miR-15a and miR-
16-1 down-regulation in pituitary adenomas.
J Cell
Physiol 2005;
204
:280
e
5.
26. Wei JS, Song YK, Durinck S, et al. The MYCN oncogene
is a direct target of miR-34a. Oncogene 2008;
27
:5204
e
13.
27. Chang TC, Wentzel EA, Kent OA, et al. Transactivation
of miR-34a by p53 broadly in
uences gene expression
and promotes apoptosis. Mol Cell 2007;
26
:745
e
52.
28. Bommer GT, Gerin I, Feng Y, et al. p53-mediated acti-
vation of miRNA34 candidate tumor-suppressor genes.
Curr Biol 2007;
17
:1298
e
307.
29. Sempere LF, Christensen M, Silahtaroglu A, et al.
Altered microRNA expression con
cation and
characterization of a novel gene, C13orf25, as a target
for 13q31-q32 ampli
c
epithelial cell subpopulations in breast cancer. Cancer
Res 2007;
67
:11612
e
20.
30. Schultz J, Lorenz P, Gross G, et al. MicroRNA let-7b
targets important cell cycle molecules in malignant
melanoma cells and interferes with anchorage-
independent growth. Cell Res 2008;
18
:549
e
57.
31. Takamizawa J, Konishi H, Yanagisawa K, et al.
Reduced expression of the let-7 microRNAs in human
lung cancers in association with shortened post-
operative survival. Cancer Res 2004;
64
:3753
e
6.
32. Zhang L, Huang J, Yang N, et al. microRNAs exhibit
high frequency genomic alterations in human cancer.
Proc Natl Acad Sci USA 2006;
103
:9136
e
41.
33. Melo SA, Moutinho C, Ropero S, et al. A genetic defect
in exportin-5 traps precursor microRNAs in the nucleus
of cancer cells. Cancer Cell 2010;
18
:303
e
15.
34. Melo SA, Ropero S, Moutinho C, et al. A TARBP2
mutation in human cancer impairs microRNA pro-
cessing and DICER1 function. Nat Genet 2009;
41
:
365
e
70.
35. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations
in familial pleuropulmonary blastoma. Science 2009;
325
:
965.
36. Heravi-Moussavi A, Anglesio MS, Cheng SW, et al.
Recurrent somatic DICER1 mutations in nonepithelial
ovarian cancers. N Engl J Med 2012;
366
:234
e
42.
37. Carninci P, Kasukawa T, Katayama S, et al. The tran-
scriptional
ned to speci
cation in malignant lymphoma.
Cancer Res 2004;
64
:3087
e
95.
14. Rinaldi A, Poretti G, Kwee I, et al. Concomitant MYC
and microRNA cluster miR-17-92 (C13orf25) amplifi-
-
cation in human mantle cell lymphoma. Leuk Lymphoma
2007;
48
:410
e
2.
15. Conkrite K, Sundby M, Mukai S, et al. miR-17~92
cooperates with RB pathway mutations to promote
retinoblastoma. Genes Dev 2011;
25
:1734
e
45.
16. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates
breast cancer cell proliferation by inhibiting translation
of AIB1 mRNA. Mol Cell Biol 2006;
26
:8191
e
201.
17. Seike M, Goto A, Okano T, et al. MiR-21 is an
EGFR-regulated anti-apoptotic factor in lung cancer in
never-smokers. Proc Natl Acad Sci USA 2009;
106
:
12085
e
90.
18. Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor
growth. Oncogene 2007;
26
:2799
e
803.
19. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is
an antiapoptotic factor in human glioblastoma cells.
Cancer Res 2005;
65
:6029
e
33.
20. Wang M, Tan LP, Dijkstra MK, et al. miRNA analysis in
B-cell chronic lymphocytic leukaemia: proliferation
centres characterized by low miR-150 and high BIC/
miR-155 expression. J Pathol 2008;
215
:13
e
20.
21. Wang M, Zhang P, Li Y, et al. The quantitative analysis
by stem-loop real-time PCR revealed the microRNA-
34a, microRNA-155 and microRNA-200c over-
expression in human colorectal cancer. Med Oncol 2012;
29
:3113
e
8.
22. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene
expression deregulation in human breast cancer. Cancer
Res 2005;
65
:7065
e
70.
23. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and
miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA 2005;
102
:13944
e
9.
landscape of
the mammalian genome.
Science 2005;
309
:1559
e
63.
38. Williams AH, Valdez G, Moresi V, et al. MicroRNA-206
delays ALS progression and promotes regeneration of
neuromuscular synapses in mice. Science 2009;
326
:
1549
e
54.
39. Salta E, De Strooper B. Non-coding RNAs with essen-
tial roles in neurodegenerative disorders. Lancet Neurol
2012;
11
:189
e
200.
Search WWH ::
Custom Search